<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04865588</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 21-0532</org_study_id>
    <nct_id>NCT04865588</nct_id>
  </id_info>
  <brief_title>Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions</brief_title>
  <acronym>ROTA-CUT</acronym>
  <official_title>Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samin Sharma, M.D., F.A.C.C., M.S.C.A.I.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rotational atherectomy is an established tool to treat blocked arteries in the heart, in&#xD;
      which the blockage is due to significant amounts of calcified material. In rotational&#xD;
      atherectomy, a rotating instrument is used to break up the calcification before a stent is&#xD;
      placed and helps restore blood flow to the heart. However, severely calcified regions are&#xD;
      difficult to treat and even after treatment arteries can re-clog and major cardiac events&#xD;
      occur. This study will test if rotational artherectomy with the addition of a cutting balloon&#xD;
      - a balloon with microsurgical blades on its outer surface which make longitudinal incisions&#xD;
      in the calcified area in order to open resistant clogs - will result in increased blood&#xD;
      vessel lumen, more optimal stent expansion and decreased cardiac problems compared to current&#xD;
      standard treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, pilot study randomizing patients with stable Coronary Artery Disease&#xD;
      undergoing Percutaneous Coronary Intervention for a de novo calcified lesion with drug&#xD;
      eluting stent implantation to angioplasty with rotational atherectomy followed by cutting&#xD;
      balloon (ROTA + CBA) or rotational artherectomy followed by plain old balloon (ROTA + POBA)&#xD;
      in a 1:1 ratio.&#xD;
&#xD;
      The clinical investigation will be conducted at 2 centers in the US. 30 randomized subjects&#xD;
      per site will be enrolled in this study. Subjects participating in this clinical&#xD;
      investigation will be followed for 9 months. The expected duration of enrollment is&#xD;
      approximately 6 months. The total duration of the clinical investigation is expected to be&#xD;
      approximately 2 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimum Stent Area after Percutaneous Coronary Intervention</measure>
    <time_frame>Day 0</time_frame>
    <description>mm^2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-segment Minimum lumen area after stent implantation</measure>
    <time_frame>Day 0</time_frame>
    <description>mm^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-segment Minimum lumen area assessed post-dilatation</measure>
    <time_frame>Day 0</time_frame>
    <description>mm^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum stent expansion after Percutaneous Coronary Intervention</measure>
    <time_frame>Day 0</time_frame>
    <description>mm^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean stent expansion after Percutaneous Coronary Intervention</measure>
    <time_frame>Day 0</time_frame>
    <description>in %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Dissection</measure>
    <time_frame>Day 0</time_frame>
    <description>A dissection or tear in the vessel wall</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Stent fracture</measure>
    <time_frame>Day 0</time_frame>
    <description>Stent fracture as a cause of drug-eluting stent failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Stent malapposition</measure>
    <time_frame>Day 0</time_frame>
    <description>Malapposition is indicated by blood visible behind stent struts. Stents may be completely or only partially malapposed depending on how much of the stent is in contact with the lumen wall.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute lumen gain after stent implantation</measure>
    <time_frame>Day 0</time_frame>
    <description>defined as the minimal luminal diameter in stent after stent implantation minus the minimal luminal diameter at baseline (prior to percutaneous coronary intervention and/or prior to stent placement).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>rotational atherectomy + cutting balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>angioplasty with rotational atherectomy followed by cutting balloon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rotational atherectomy + plain old balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>angioplasty with rotational atherectomy followed by plain old balloon</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>rotational atherectomy</intervention_name>
    <description>angioplasty with rotational atherectomy - a rotating instrument used to break up the calcification</description>
    <arm_group_label>rotational atherectomy + cutting balloon</arm_group_label>
    <arm_group_label>rotational atherectomy + plain old balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cutting balloon</intervention_name>
    <description>a balloon with microsurgical blades on its outer surface which make longitudinal incisions in the calcified area in order to open resistant clogs</description>
    <arm_group_label>rotational atherectomy + cutting balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>plain old balloon</intervention_name>
    <description>current standard treatment of stent placement</description>
    <arm_group_label>rotational atherectomy + plain old balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Adults Patients ≥18 years of age&#xD;
&#xD;
          -  Patients undergoing percutaneous coronary intervention with planned rotational&#xD;
             atherectomy and planned drug-eluting stent implantation of a lesion with target vessel&#xD;
             reference diameter ≥2.5 mm and ≤ 4.0mm, lesion length ≥ 5 mm and moderate to severe&#xD;
             calcification by angiography&#xD;
&#xD;
          -  Patients eligible for percutaneous coronary intervention&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Patients in cardiogenic shock&#xD;
&#xD;
          -  Planned surgery (cardiac and non-cardiac) within 6 months after the index procedure&#xD;
             unless the dual-antiplatelet therapy can be maintained throughout the perisurgical&#xD;
             period&#xD;
&#xD;
          -  Patients undergoing primary percutaneous coronary intervention for ST-segment&#xD;
             elevation myocardial infarction&#xD;
&#xD;
          -  Subject is pregnant, nursing, or is a woman of child-bearing potential who is not&#xD;
             surgically sterile, &lt; 2 years postmenopausal, or does not consistently use effective&#xD;
             methods of contraception&#xD;
&#xD;
          -  Patient has any other serious medical illness (e.g., cancer, end-stage congestive&#xD;
             heart failure) that may reduce life expectancy to less than 12 months&#xD;
&#xD;
          -  Currently participating in another investigational drug or device study&#xD;
&#xD;
          -  Patients referred to coronary artery bypass grafting after heart team discussion&#xD;
&#xD;
        Angiographic Specific Exclusion Criteria:&#xD;
&#xD;
          -  Lesion(s) with angulation &gt; 45 degrees by visual estimate&#xD;
&#xD;
          -  Lesion(s) stenosis through which a guidewire will not pass.&#xD;
&#xD;
          -  Last remaining vessel with compromised (&lt;30%) left ventricular function&#xD;
&#xD;
          -  Saphenous vein grafts&#xD;
&#xD;
          -  Angiographic evidence of thrombus&#xD;
&#xD;
          -  Angiographic evidence of significant dissection at the treatment site&#xD;
&#xD;
          -  Lesion(s) with previously placed stent within 10 mm (visual estimate)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samin K Sharma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Regina Hanstein</last_name>
    <phone>212-659-9361</phone>
    <email>regina.hanstein@mountsinai.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Samin Sharma, M.D., F.A.C.C., M.S.C.A.I.</investigator_full_name>
    <investigator_title>Professor of Medicine/Cardiology</investigator_title>
  </responsible_party>
  <keyword>calcified plaque</keyword>
  <keyword>angioplasty</keyword>
  <keyword>cutting balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

